Psiquiatria Biologica最新文献

Síndrome de encefalopatía posterior reversible tras la terapia electroconvulsiva 电休克疗法（ECT）后可逆性后遗可逆性脑病综合征

Psiquiatria Biologica Pub Date : 2024-10-19 DOI: 10.1016/j.psiq.2024.100515

Andrea Jiménez-Mayoral , Emilio Ruiz-Fernández , Aurora Torrent-Seto , Iolanda Batalla-Llordes

{"title":"Síndrome de encefalopatía posterior reversible tras la terapia electroconvulsiva","authors":"Andrea Jiménez-Mayoral , Emilio Ruiz-Fernández , Aurora Torrent-Seto , Iolanda Batalla-Llordes","doi":"10.1016/j.psiq.2024.100515","DOIUrl":"10.1016/j.psiq.2024.100515","url":null,"abstract":"<div><h3>Introduction</h3><div>Electroconvulsive therapy (ECT) is a safe technique in which adverse effects are usually mild and self-limited. Posterior reversible encephalopathy syndrome (PRES) is a clinical-radiological entity characterized by encephalopathy, headache, seizures and visual alterations of acute evolution, caused by noxas that produce endothelial damage with vasogenic edema in the cerebral vessels. PRES has been described as a rare neurological complication associated of ECT. A case report is proposed to facilitate PRES recognition and management.</div></div><div><h3>Material and methods</h3><div>We present a clinical case report of a young woman with diagnosis of obsessive-compulsive disorder and eating disorder who was admitted due to a torpid evolution, who in the context of an ECT trial, suffered a PRES. Informed consent was obtained for every test performed, and for the use of their results in this publication. This publication complies with the agreements of the Declaration of Helsinki.</div></div><div><h3>Results</h3><div>The patient presented a spontaneous and complete recovery within a week, with no alterations on the MRI and no new neurological symptoms during admission or in the months after discharge. Even so, it was decided to suspend the ECT sessions.</div></div><div><h3>Discussion</h3><div>Patient’s symptoms were highly suggestive of PRES. MRI findings were unremarkable, which we attribute to the characteristic reversibility of the syndrome and the patients’ rapid clinical recovery after discontinuation of ECT.</div></div><div><h3>Conclusion</h3><div>Despite its reversibility and good prognosis, it is important to know this entity as a possible complication of ECT to facilitate its early recognition and improve the management and prognosis of our patients.</div></div>","PeriodicalId":39337,"journal":{"name":"Psiquiatria Biologica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142661802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Síndrome delirante en el contexto de consumo de cannabis 吸食大麻导致的妄想综合征

Psiquiatria Biologica Pub Date : 2024-10-09 DOI: 10.1016/j.psiq.2024.100514

Mar González Testón, Elena Blanco Martín, Susana Macayo Villalobos, Marta Ramírez Bravo

引用次数: 0

Innovaciones en la cesación tabáquica: el papel de la citisiniclina 戒烟创新：胞二磷胆碱的作用

Psiquiatria Biologica Pub Date : 2024-10-01 DOI: 10.1016/j.psiq.2024.100513

Miguel Angel Alvarez de Mon, Vanessa Herrera

{"title":"Innovaciones en la cesación tabáquica: el papel de la citisiniclina","authors":"Miguel Angel Alvarez de Mon, Vanessa Herrera","doi":"10.1016/j.psiq.2024.100513","DOIUrl":"10.1016/j.psiq.2024.100513","url":null,"abstract":"<div><div>Tobacco use is one of the leading causes of disease, disability, and death worldwide. Achieving smoking cessation without pharmacological assistance is extremely challenging due to the highly addictive nature of tobacco. The goal of pharmacotherapy for nicotine addiction is to reduce withdrawal symptoms and nicotine's reinforcing effects with minimal side effects. Several effective medications are available to help people quit smoking, including nicotine replacement therapy (NRT), bupropion, varenicline, nortriptyline, and cytisinicline, among others. Cytisinicline has gained popularity in Spain, supported by funding from the Ministry of Health, making it more accessible through the public health system. Cytisinicline is administered orally and does not undergo significant hepatic metabolism, reducing the risk of drug interactions. Its most common side effects are gastrointestinal symptoms, which usually resolve spontaneously. Clinical trials have demonstrated its efficacy in smoking cessation. A clinical trial in Australia compared cytisinicline with varenicline, showing similar abstinence rates but with better tolerability for cytisinicline. Other studies and meta-analyses have also demonstrated the superiority of cytisinicline over NRT and placebo. Given its effectiveness, favorable side effect profile, and low cost, cytisinicline is a promising option. Combining it with behavioral support, such as cognitive-behavioral therapy (CBT) and motivational interviewing, enhances outcomes.</div></div>","PeriodicalId":39337,"journal":{"name":"Psiquiatria Biologica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142586847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Risk of hospital readmission in patients with psychotic symptoms and a history of drug use 有精神病症状和吸毒史的患者再次入院的风险

Psiquiatria Biologica Pub Date : 2024-10-01 DOI: 10.1016/j.psiq.2024.100509

Paula Mollà Roig

{"title":"Risk of hospital readmission in patients with psychotic symptoms and a history of drug use","authors":"Paula Mollà Roig","doi":"10.1016/j.psiq.2024.100509","DOIUrl":"10.1016/j.psiq.2024.100509","url":null,"abstract":"<div><h3>Introduction</h3><div>Substance use is common in patients with psychotic symptomatology, especially in patients diagnosed with a first psychotic episode or schizophrenia. In both chronic psychosis and first psychotic episodes, substance abuse is associated with a worse outcome and a higher relapse rate.</div></div><div><h3>Methods</h3><div>For this study, a sample of <em>n</em>      <!-->15.08 years). In addition, drug use was more frequent in males, with a ratio of 4:1.</div></div><div><h3>Conclusions</h3><div>It has also been observed that patients with a history of drug use have a higher risk of hospital readmission to a psychiatric unit. In the sample analysed, cannabis was the only substance that presented statistically significant differences with respect to the risk of hospital readmission.</div></div>","PeriodicalId":39337,"journal":{"name":"Psiquiatria Biologica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142420158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Bioética en la salud mental. Dilemas actuales ante nuevas condiciones emergentes 精神卫生领域的生物伦理。面对新出现情况的当前困境

Psiquiatria Biologica Pub Date : 2024-10-01 DOI: 10.1016/j.psiq.2024.100508

Francisco Angel Nente Chávez, Martha Díaz Rodríguez

引用次数: 0

Concordancia del autorreporte y la valoración clínica de la ideación suicida 自杀意念自我报告与临床评估的一致性

Psiquiatria Biologica Pub Date : 2024-10-01 DOI: 10.1016/j.psiq.2024.100510

Constanza Vera-Varela , María Luisa Barrigón , Enrique Baca-García

{"title":"Concordancia del autorreporte y la valoración clínica de la ideación suicida","authors":"Constanza Vera-Varela , María Luisa Barrigón , Enrique Baca-García","doi":"10.1016/j.psiq.2024.100510","DOIUrl":"10.1016/j.psiq.2024.100510","url":null,"abstract":"<div><h3>Background</h3><div>Thoughts of suicide and/or death usually precede suicide attempts and suicide deaths. We study the agreement in passive suicidal ideation between reports made by clinicians during an outpatient mental health service and patients’ online self-reports.</div></div><div><h3>Methodology</h3><div>Between 2014 and 2016, during routine psychiatric and psychological appointments in the outpatient mental-health facilities affiliated with the Fundación Jiménez Díaz Hospital in Madrid, wish of death was assessed in 25.358 patients.</div><div>Within 24 hours of this assessment, 648 patients completed a self-report in which they were asked about the presence of passive suicidal ideation. We used cluster analysis to determine the clinical profile of a population of patients according to the agreement between reports made by clinicians and self-reported information.</div></div><div><h3>Results</h3><div>A low level of agreement (kappa=0.072) was found between clinicians and patients, as 56.4% (n=366) of clinicians’ reports classified as containing no death-related ideas, although on self-report the patient did state that they had passive suicidal ideation. In this group, two clusters (cluster 2 y 4) were found to have shared characteristics: female sex, middle age, cohabitation, active employment, no history of suicidal behavior, and diagnosis of neurotic, stress-related, and somatoform disorders. Additionally, cluster 4 patients self-reported sleep disturbances, less appetite, poor treatment adherence, and aggressiveness.</div></div><div><h3>Conclusions</h3><div>We found low agreement between patients’ self-reports and clinician assessments regarding the passive suicidal ideation. Self-report may be useful in suicide risk assessment as a complementary method, that allows to generate a confidential space that could reduce the problem of underreporting of passive suicidal ideation.</div></div>","PeriodicalId":39337,"journal":{"name":"Psiquiatria Biologica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142420159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Case report. Pregnancy in women with an eating disorder 病例报告。患有饮食失调症的妇女怀孕

Psiquiatria Biologica Pub Date : 2024-10-01 DOI: 10.1016/j.psiq.2024.100511

Belén Resa-Pérez , Andrea Jiménez-Mayoral , Vanessa Gladys Velasquez-Acebey , Filip Damian Budny , Georgina Badia i Realp , Salvador Miret-Fallada , María Irigoyen-Otiñano

{"title":"Case report. Pregnancy in women with an eating disorder","authors":"Belén Resa-Pérez , Andrea Jiménez-Mayoral , Vanessa Gladys Velasquez-Acebey , Filip Damian Budny , Georgina Badia i Realp , Salvador Miret-Fallada , María Irigoyen-Otiñano","doi":"10.1016/j.psiq.2024.100511","DOIUrl":"10.1016/j.psiq.2024.100511","url":null,"abstract":"<div><h3>Introduction</h3><div>Pregnancy has been described as a period of symptomatic stability for women diagnosed with eating disorder (ED). However, a poor control of alimentary symptoms before and during pregnancy is associated with higher risk of adverse effects during childbirth and the postpartum period. A case report is presented and a bibliographic review is carried out.</div></div><div><h3>Methods</h3><div>The authors take the case of a 33-year-old woman diagnosed with anorexia nervosa during adolescence, who becomes pregnant at the age of 30. A non-systematic review was carried out using the Pubmed database using keywords [eating disorder] AND [pregnancy]. Studies of more than 5 years were excluded. The patient's informed consent was obtained. This work complies with the agreements of the Declaration of Helsinki.</div></div><div><h3>Results</h3><div>Eutocic delivery was carried out without incidents. Currently, the baby is 5 months old, his weight is adjusted to his age and his neurodevelopment is normal. Although the patient denies restrictions or purgative behaviors, she has lost weight in postpartum and has recovered her pre-pregnancy body mass index. No major affective symptoms have been observed in this period.</div></div><div><h3>Discussion/Conclusions</h3><div>Pregnancy and postpartum period constitute periods of greater vulnerability in terms of eating symptoms in patients with EDs. Emphasis should be placed on a multidisciplinary approach with the aim of avoiding the appearance of associated risk factors both for the mother and the baby.</div></div>","PeriodicalId":39337,"journal":{"name":"Psiquiatria Biologica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142420157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Cognición y conducta suicida en psicosis y depresión 精神病和抑郁症患者的认知和自杀行为

Psiquiatria Biologica Pub Date : 2024-09-26 DOI: 10.1016/j.psiq.2024.100512

Aina Sastre-Buades , Enrique Baca-Garcia , Maria Luisa Barrigon

引用次数: 0

Síntomas de ansiedad y depresión en los trabajadores de la salud durante la pandemia por COVID-19 en un centro de salud en Barranquilla, Colombia 哥伦比亚巴兰基亚一家医疗中心的医护人员在 COVID-19 大流行期间的焦虑和抑郁症状

Psiquiatria Biologica Pub Date : 2024-09-03 DOI: 10.1016/j.psiq.2024.100505

Erika Arenas-Contreras , Laura Ariza-Teheran , Laura Borja-Egher , Omaira Diaz-Granados , Oriana Mora-Cartusciello , Lawren Thowinsson-Merizalde , Karina Cure-Aragón , Tania Acosta-Vergara , Edwin Guevara-Romero , Victor Florez-Garcia

{"title":"Síntomas de ansiedad y depresión en los trabajadores de la salud durante la pandemia por COVID-19 en un centro de salud en Barranquilla, Colombia","authors":"Erika Arenas-Contreras , Laura Ariza-Teheran , Laura Borja-Egher , Omaira Diaz-Granados , Oriana Mora-Cartusciello , Lawren Thowinsson-Merizalde , Karina Cure-Aragón , Tania Acosta-Vergara , Edwin Guevara-Romero , Victor Florez-Garcia","doi":"10.1016/j.psiq.2024.100505","DOIUrl":"10.1016/j.psiq.2024.100505","url":null,"abstract":"<div><h3>Introduction</h3><p>The spread of the pandemic in Colombian territory occurred heterogeneously, suggesting a potentially differential impact on the mental health of healthcare professionals who responded to the emergency.</p></div><div><h3>Objective</h3><p>To identify factors related to depressive and anxious symptoms in healthcare workers during the COVID-19 pandemic at a clinical center in the city of Barranquilla.</p></div><div><h3>Methodology</h3><p>We conducted a cross-sectional study involving 71 active healthcare workers in 2022. The Patient Health Questionnaire (PHQ-9) and the Generalized Anxiety Disorder scale (GAD-7) were utilized to estimate the prevalence of these mental disorders.</p></div><div><h3>Results</h3><p>We estimated a prevalence of depressive and anxious symptoms, mild or higher, at 18.3% (CI95% 10.1–29.3) and 21.1% (CI95% 12.3–33.4), respectively. Work experience, glove usage, gastrointestinal discomfort, and appetite disturbance were significantly associated with depressive symptoms, while loss of libido and appetite disturbance were linked to mild or higher anxious symptoms.</p></div><div><h3>Conclusions</h3><p>Depressive and anxious symptoms are common in the mental health of healthcare workers in pandemic contexts. Factors associated with these symptoms, such as the use of personal protective equipment and work experience, could be addressed through organizational management.</p></div>","PeriodicalId":39337,"journal":{"name":"Psiquiatria Biologica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142270963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Efectos terapéuticos de las plantas medicinales en los trastornos de ansiedad. Revisión exploratoria 药用植物对焦虑症的治疗效果。探索性综述

Psiquiatria Biologica Pub Date : 2024-09-02 DOI: 10.1016/j.psiq.2024.100495

Jose Luis Estela-Zape , Diana Carolina Libreros-Chica , Lizeth Dayana Noreña-Buitrón , Jose Miguel Sierra-Olea

{"title":"Efectos terapéuticos de las plantas medicinales en los trastornos de ansiedad. Revisión exploratoria","authors":"Jose Luis Estela-Zape , Diana Carolina Libreros-Chica , Lizeth Dayana Noreña-Buitrón , Jose Miguel Sierra-Olea","doi":"10.1016/j.psiq.2024.100495","DOIUrl":"10.1016/j.psiq.2024.100495","url":null,"abstract":"<div><h3>Objective</h3><p>Describe the therapeutic effects of medicinal plants in anxiety disorders.</p></div><div><h3>Methods</h3><p>Scoping review conducted by the guidelines (PRISMA-ScR). Scopus, Web of Science and PubMed were searched for original articles, clinical trials and case series that explained the effects of medicinal plants used as anxiolytic agents in English and without publication date restrictions.</p></div><div><h3>Results</h3><p>A total of 735 records were initially identified. After eliminating duplicates and applying eligibility criteria, 11 studies were included that described the neurobiological actions of medicinal plants in relation to anxiety. The studies highlighted the benefit of plants by regulating neurotransmitters and various neurobiological systems, influencing the modulation of neuronal and neurochemical responses associated with the disorder.</p></div><div><h3>Conclusions</h3><p>Studies support the effectiveness of herbal therapy in reducing anxiety, but further research is required to validate its effectiveness, clinical safety, and potential drug interactions.</p></div>","PeriodicalId":39337,"journal":{"name":"Psiquiatria Biologica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142270964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0